{{slotProps.result.Title}} {{slotProps.result.Title}} {{slotProps.result.Title}} {{slotProps.result.Title}}

Maurice Hoo

Registered Foreign Lawyer

Maurice Hoo has more than 30 years of experience advising private equity and venture capital investors, as well as multinationals, family offices, and strategic investors, in their cross-border mergers, acquisitions, investments, restructurings, and divestments. Maurice is a Registered Foreign Lawyer in Hong Kong and is admitted to practice in California.

report report

EMEA Private Equity: A Look Ahead at 2024

resource resource

US-China Trading Policy & Global Impact

Maurice’s deal experience spans a wide range of industries, including life sciences and medical devices, environmental protection and renewable energy, food, media and entertainment, financial services, retail, and telecommunications, media, and technology (TMT).

Since 2008, Maurice has been consistently recognized as one of the top private equity lawyers in China by legal industry publications Chambers Asia-Pacific and IFLR1000. Clients have praised Maurice and his team as “innovative,” “thinks outside the box,” “gives us lots of alternatives,” and “offers high-calibre service.”

  • 1990年 ハーバード・ロー・スクール (J.D.)
  • 1987年 Boston University (B.S. Business Administration summa cum laude)
  • California
  • Registered Foreign Lawyer in Hong Kong

Ranked, Private Equity: Buyouts & Venture Capital Investment (International Firms), Chambers Greater China Region (2022–2024)

Recognized, Mergers & Acquisitions: International Firms, China (Highly Recommended), Leaders League and Décideurs (2021)

Recognized, Mergers & Acquisitions: Private Equity: International Firms, China (Valuable Practice), Leaders League and Décideurs (2021)

Ranked, Private Equity: Buyouts & Venture Capital Investment (International Firms), China, Chambers Asia-Pacific (2008–2021)

The A-List, China Business Law Journal (2020)

Recommended, Corporate and M&A: Foreign Firms, The Legal 500 Asia Pacific: China (2024, 2025)

Recommended, Corporate (including M&A), Hong Kong, The Legal 500 Asia Pacific: China (2025)

Recommended, Life Sciences and Healthcare: Foreign Firms, The Legal 500 Asia Pacific: China (2024, 2025)

Recommended, Private Equity, Hong Kong, The Legal 500 Asia Pacific: China (2025)

Recommended, Private Equity: Foreign Firms, The Legal 500 Asia Pacific: China (2023–2025)

Recommended, TMT: Foreign Firms, The Legal 500 Asia Pacific: China (2023–2025)

Recommended, Corporate and M&A: Foreign Firms, China, The Legal 500 Asia Pacific (2019–2021)

Recommended, Private Equity: Foreign Firms, China, The Legal 500 Asia Pacific (2020, 2021)

Recommended, Corporate and M&A: Foreign Firms, China, The Legal 500 Asia Pacific (2019)

Recommended, Private Equity/Venture Capital: Foreign Firms, China, The Legal 500 Asia Pacific (2018, 2019)

Recommended, Corporate (including M&A); Private Equity, Hong Kong, The Legal 500 Asia Pacific (2018–2021)

Recognized, M&A/Private Equity, IFLR1000 (2011–2012, 2014–2016)

Recognized, Leading Lawyer in Hong Kong, Asialaw Leading Lawyers (2012–2013)

Notable Practitioner, IFLR1000 Financial and Corporate (2023)

Highly Regarded, IFLR1000 Financial and Corporate (2019–2023)